Author
Listed:
- Mohd Waseem Akhtar
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute)
- Sara Sanz-Blasco
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute
Present address: Instituto de Investigaciones Farmacológicas (ININFA) CONICET—UBA Junín 956 5to Piso, 1113 Buenos Aires, Argentina.)
- Nima Dolatabadi
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute
Neurodegenerative Disease Center, Scintillon Institute)
- James Parker
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute
Neurodegenerative Disease Center, Scintillon Institute)
- Kevin Chon
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute)
- Michelle S. Lee
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute)
- Walid Soussou
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute
Quantum Applied Science and Research)
- Scott R. McKercher
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute
Neurodegenerative Disease Center, Scintillon Institute)
- Rajesh Ambasudhan
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute
Neurodegenerative Disease Center, Scintillon Institute)
- Tomohiro Nakamura
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute
Neurodegenerative Disease Center, Scintillon Institute)
- Stuart A. Lipton
(Center for Neuroscience and Aging Research, Sanford Burnham Prebys Medical Discovery Institute
Neurodegenerative Disease Center, Scintillon Institute
University of California, San Diego, School of Medicine)
Abstract
Metabolic syndrome (MetS) and Type 2 diabetes mellitus (T2DM) increase risk for Alzheimer’s disease (AD). The molecular mechanism for this association remains poorly defined. Here we report in human and rodent tissues that elevated glucose, as found in MetS/T2DM, and oligomeric β-amyloid (Aβ) peptide, thought to be a key mediator of AD, coordinately increase neuronal Ca2+ and nitric oxide (NO) in an NMDA receptor-dependent manner. The increase in NO results in S-nitrosylation of insulin-degrading enzyme (IDE) and dynamin-related protein 1 (Drp1), thus inhibiting insulin and Aβ catabolism as well as hyperactivating mitochondrial fission machinery. Consequent elevation in Aβ levels and compromise in mitochondrial bioenergetics result in dysfunctional synaptic plasticity and synapse loss in cortical and hippocampal neurons. The NMDA receptor antagonist memantine attenuates these effects. Our studies show that redox-mediated posttranslational modification of brain proteins link Aβ and hyperglycaemia to cognitive dysfunction in MetS/T2DM and AD.
Suggested Citation
Mohd Waseem Akhtar & Sara Sanz-Blasco & Nima Dolatabadi & James Parker & Kevin Chon & Michelle S. Lee & Walid Soussou & Scott R. McKercher & Rajesh Ambasudhan & Tomohiro Nakamura & Stuart A. Lipton, 2016.
"Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation,"
Nature Communications, Nature, vol. 7(1), pages 1-11, April.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10242
DOI: 10.1038/ncomms10242
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10242. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.